Evidence map›Paper›PMID 39601892›Full record

ArticleLung2024

COPD Risk Phenotypes in Older Smokers: Evaluation in GLI- and GOLD-Defined Respiratory Impairment.

Abraham Bohadana, Pascal Wild, Ariel Rokach, Assaf Berg, Gabriel Izbicki

Abstract read
In one paragraph

Article in Lung, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Abraham BohadanaDepartment of Medicine, Shaare Zedek Medical Center and Faculty of Medicine, Respiratory Research Unit, Pulmonary Institute, Hebrew University of Jerusalem, 12, Bayit Street, 91031, Jerusalem, Israel. abraham.bohadana@gmail.com.ORCID 0000-0002-0411-8570
Pascal WildPW Statistical Consulting, 54000, Laxou, France.ORCID 0000-0003-3165-3808
Ariel RokachDepartment of Medicine, Shaare Zedek Medical Center and Faculty of Medicine, Respiratory Research Unit, Pulmonary Institute, Hebrew University of Jerusalem, 12, Bayit Street, 91031, Jerusalem, Israel.ORCID 0000-0001-6339-7699
Assaf BergHadassah School of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.ORCID 0009-0006-4730-6703
Gabriel IzbickiDepartment of Medicine, Shaare Zedek Medical Center and Faculty of Medicine, Respiratory Research Unit, Pulmonary Institute, Hebrew University of Jerusalem, 12, Bayit Street, 91031, Jerusalem, Israel.ORCID 0000-0002-3455-5480

Funding

Israel Lung and Tuberculosis Association xxIsrael Lung Association Tel Aviv xxLouzoun Family Research Fund (Nissim and Gittel Rivka Louzoun and Family Pulmonary Fund) xxx
6 · The paper itself

Abstract

purposeIn aging populations, the Global Initiative for Obstructive Lung Disease (GOLD) spirometry threshold may misclassify normal spirometry as airflow limitation. The Global Lung Initiative (GLI) method provides age-adjusted criteria. We investigated how the use of GOLD or GLI thresholds in an algorithm affects the classification of elderly smokers into COPD risk phenotypes.

methodsUsing a modified COPDGene algorithm, including exposure, symptoms, and abnormal spirometry, 200 smokers aged 60 years and older were classified into 4 mutually exclusive phenotypes: Phenotype A (no symptoms, normal spirometry; reference), Phenotype B (symptoms, normal spirometry; possible COPD), Phenotype C (no symptoms, abnormal spirometry; possible COPD), and Phenotype D (symptoms, abnormal spirometry; probable COPD). Abnormal spirometry was defined according to the GOLD or GLI criteria. A comparison was made between the GOLD- and GLI-defined phenotypes.

resultsUsing GLI criteria/cut-offs, 18.5% (n = 37) had phenotype A (no COPD), 42% (n = 84) had phenotype B (possible COPD), 7.5% (n = 15) had phenotype C (possible COPD), and 32% (n = 64) had phenotype D (probable COPD). Using GOLD criteria cut-offs, 14.5% (n-29) had phenotype A (no COPD); 31% (n = 62) had phenotype B, 11.5% (n = 23) had phenotype C (probable COPD), and 43% (n = 86) had phenotype D (probable COPD). Eight smokers with GOLD phenotype C were reclassified as GLI phenotype A, while 22 with GOLD phenotype D were reclassified as GLI phenotype B. Smokers identified as ‟probable COPD" by GOLD alone (potential false positives) had better spirometry results than those identified as ‟probable COPD" by both GOLD and GLI.

conclusionThe use of the GOLD threshold in an algorithm resulted in older smokers being classified into more severe COPD risk phenotypes compared to the GLI threshold. This suggests that GOLD may misclassify smokers with less affected phenotypes as having respiratory impairment, potentially leading to unnecessary and harmful treatments.

Indexed as

PhenotypePulmonary Disease, Chronic ObstructiveSpirometryAgedAge FactorsAlgorithmsFemaleForced Expiratory VolumeHumansLungMaleMiddle AgedRisk AssessmentRisk FactorsSmokersSmokingCOPD risk phenotypeElderly smokersGLIGOLDMisclassificationSpirometry

Identifiers

PMID39601892
PMCPMC11602840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.